Potentially Harmful Medication Use and Decline in Health-Related Quality of Life among Community-Dwelling Older Adults
Supporting Files
-
Dec 2017
-
File Language:
English
Details
-
Alternative Title:Drugs Real World Outcomes
-
Personal Author:
-
Description:Background
Several scales to quantify the impact of potentially harmful medications (PHMs) have been shown to predict mortality and functional decline; however, the effect of PHMs on quality of life (QoL) has not been well-studied.
Objective
The aims of this study were to investigate an association between PHM use and change in health-related QoL among community-dwelling older adults, and to compare the predictive capacity of PHM scales.
Methods
We conducted a retrospective cohort study using prescription claims data and survey responses. A total of 426 community-dwelling adults aged 65 years or older who visited senior centers and had received prescriptions through a statewide prescription drug subsidy program were included. Anticholinergic Cognitive Burden (ACB), Drug Burden Index-sedative component (DBI-Se), Drug Burden Index-anticholinergic component (DBI-ACh), and the number of regular medications and Beers list medications were calculated from the claims data between baseline and 12 months. In addition, change in the EuroQoL five-dimensions questionnaire (EQ-5D) between baseline and 6- and 12-month follow-up were measured as the main outcome. A linear mixed model was used for the analysis.
Results
After adjusting for covariates, both DBI-Se (coefficients − 0.076, 95% confidence interval [CI] − 0.131 to − 0.020) and DBI-Ach (coefficients − 0.095, 95% CI − 0.188 to − 0.002) significantly predicted a decline in EQ-5D index. The ACB, number of regular medications, and number of Beers medications did not have a significant association with EQ-5D changes.
Conclusions
PHM measures incorporating dose revealed a better predictive capacity for QoL change. Reducing cumulative drug dose, as well as stopping medications, would be important for the well-being of this population.
Electronic supplementary material
The online version of this article (10.1007/s40801-017-0123-8) contains supplementary material, which is available to authorized users.
-
Subjects:
-
Source:Drugs Real World Outcomes. 4(4):257-264.
-
Pubmed ID:29119486
-
Pubmed Central ID:PMC5684052
-
Document Type:
-
Funding:P30 AG024827/AG/NIA NIH HHS/United States ; R01 LM011838/LM/NLM NIH HHS/United States ; K01 AG044433/National Institute of Aging/United States ; U48 DP002657/DP/NCCDPHP CDC HHS/United States ; AG024827/National Institutes of Health/United States ; DP002657/Centers for Disease Control and Prevention/United States ; K01 AG044433/AG/NIA NIH HHS/United States
-
Volume:4
-
Issue:4
-
Collection(s):
-
Main Document Checksum:urn:sha256:74397980e44b1e9b6be95a51cc265c8cb2d8e02b82dbc6517caf6bef83dff1ae
-
Download URL:
-
File Type:
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access